| TRADING CENTER |
| Last trade | Change/%change | P/E ratio | ||
|---|---|---|---|---|
| AMGN | Amgen Inc | 57.35 | 0.13 / 0.23% | 10.97 |
| GILD | Gilead Sciences Inc | 43.01 | -0.23 / -0.53% | 16.61 |
| CELG | Celgene Corporation | 56.80 | 0.51 / 0.91% | 68.43 |
| 2008 Revenue: | $194.3 M | Headquarters: Emeryville, CA |
| Employees: | 197 | CEO: Dr. N. Anthony Coles, M.D. |
| Net Income: | $1.9 M | Industry: Biotechnology |
| Market Cap: | $1.8 B | Website: www.onyx-pharm.com |
| Symbol | Price | Change/%Change | Prev. close | High | Low | Last Update | More Info |
|---|---|---|---|---|---|---|---|
| ONXX | 29.21 | +0.20 / +0.69% | 29.01 | 29.29 | 28.99 | Profile Chart News |